Grayslake, IL, United States of America

Sridhar Peddi

USPTO Granted Patents = 32 

 

Average Co-Inventor Count = 7.2

ph-index = 8

Forward Citations = 115(Granted Patents)


Location History:

  • Grayslake, IL (US) (2007 - 2015)
  • Schaumburg, IL (US) (2013 - 2015)

Company Filing History:


Years Active: 2007-2015

Loading Chart...
Loading Chart...
32 patents (USPTO):Explore Patents

Title: Innovations of Sridhar Peddi: A Beacon in Cannabinoid Research

Introduction

Sridhar Peddi, based in Grayslake, Illinois, has made significant contributions to the field of pharmaceutical sciences, particularly in cannabinoid research. With an impressive portfolio of 32 patents, he continues to innovate and advance the understanding of cannabinoid receptor ligands and their therapeutic applications.

Latest Patents

Among his latest patents is a groundbreaking invention regarding compounds as cannabinoid receptor ligands. This invention focuses on compounds of a specific formula, which are designed for pharmaceutical compositions that can be applied in treating various conditions and disorders. Another notable patent involves similar compounds, again defined within the specification, aimed at enhancing therapeutic treatments through innovative compositions and methods using these cannabinoids.

Career Highlights

Sridhar has had a prolific career, with key stints at prominent firms such as AbbVie Inc. and Abbott Laboratories Corporation. His work in these organizations has not only enhanced their research capabilities but has also contributed significantly to the expansion of their pharmaceutical offerings.

Collaborations

During his career, Sridhar has collaborated with other experts in the field, including colleagues like Arturo Perez-Medrano and William A. Carroll. These collaborations have fostered an environment of innovation and creativity, leading to groundbreaking developments in cannabinoid research.

Conclusion

Sridhar Peddi stands out as a prominent inventor and innovator, particularly in the realm of cannabinoid receptor research. His extensive patent portfolio reflects a commitment to advancing medical science, with profound implications for treating various health conditions. Through his work and collaborations, he continues to influence the pharmaceutical landscape, paving the way for future discoveries.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…